Eugenia Litz
Head of Investor Relations, Recordati
Replay available
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q1 2026 Earnings Call
Recordati Industria Chimica e Farmaceutica S.p.A. (OTC: RCDTF) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Scott Pescatore
Executive Vice President, Rare Diseases
Milan Draskovic
Executive Vice President, R&D
Alberto Martinez
Executive Vice President, Specialty and Primary Care
Christy Roth-Stewart
Analyst, BNP Paribas
Sophia Graf Doolnesson
Analyst, J.P. Morgan
Nicolas Storer
Analyst, Kepler Cheuvreux
Martino D'Ambrogi
Analyst, Equita
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Recordati S.p.a..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.079 Corusco Conference Operator. Welcome and thank you for joining the Recordati First 00:00:05.079 -- 00:00:07.143 Quarter 2026 Results 00:00:07.143 -- 00:00:12.191 Conference Call. As a reminder, all participants are in listen-only mode. 00:00:12.191 -- 00:00:16.278 After the presentation, there will be an opportunity to ask questions. 00:00:16.278 -- 00:00:20.745 Should anyone need assistance during the conference call, they may signal an operator 00:00:20.745 -- 00:00:23.470 by pressing star and zero on their telephone. 00:00:23.470 -- 00:00:27.435 At this time, I would like to turn the conference over to Ms. 00:00:27.435 -- 00:00:31.978 Eugenia Litz, Investor Relations of Recordette. 00:00:40.851 -- 00:00:45.296 ...PFO, who together will present results for the first quarter of 2026. 00:00:45.296 -- 00:00:50.382 Scott Pescatore, Executive Vice President of Rare Diseases, 00:00:50.382 -- 00:00:55.846 will then... provide an update on Isteriza, and Milan Draskovic, Executive 00:00:55.846 -- 00:01:00.575 Vice President of R&D, will provide an update on our pipeline programs. 00:01:00.575 -- 00:01:06.025 Also joining for the Q&A session will be Alberto Martinez, Executive Vice President 00:01:06.025 -- 00:01:11.576 of Specialty and Primary Care. As always, the presentation is available in the Investor 00:01:11.576 -- 00:01:13.576 section. 00:01:19.799 -- 00:01:23.565 Good evening. Thank you all for joining us today. 00:01:23.565 -- 00:01:29.576 We're off to a really good start to the year, as reflected in our Q1 results, 00:01:29.576 -- 00:01:35.165 delivering excellent financial performance and solid progress across the business. 00:01:35.165 -- 00:01:40.032 We remain very well positioned to achieve our full year objectives. 00:01:40...